Feb 13 (Reuters) -
* FIRST PATIENT DOSED IN PIVOTAL PHASE 3 TRIAL OF SNF472 IN CALCIPHYLAXIS Source text for Eikon:
Our Standards: The Thomson Reuters Trust Principles.
Feb 13 (Reuters) -
* FIRST PATIENT DOSED IN PIVOTAL PHASE 3 TRIAL OF SNF472 IN CALCIPHYLAXIS Source text for Eikon:
Our Standards: The Thomson Reuters Trust Principles.